1. Home
  2. CASI vs WETH Comparison

CASI vs WETH Comparison

Compare CASI & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • WETH
  • Stock Information
  • Founded
  • CASI 1991
  • WETH 1992
  • Country
  • CASI China
  • WETH China
  • Employees
  • CASI N/A
  • WETH N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • CASI Health Care
  • WETH
  • Exchange
  • CASI Nasdaq
  • WETH Nasdaq
  • Market Cap
  • CASI 24.9M
  • WETH 26.1M
  • IPO Year
  • CASI 1996
  • WETH N/A
  • Fundamental
  • Price
  • CASI $1.30
  • WETH $2.54
  • Analyst Decision
  • CASI Strong Buy
  • WETH
  • Analyst Count
  • CASI 1
  • WETH 0
  • Target Price
  • CASI $4.00
  • WETH N/A
  • AVG Volume (30 Days)
  • CASI 26.7K
  • WETH 467.7K
  • Earning Date
  • CASI 11-14-2025
  • WETH 11-12-2025
  • Dividend Yield
  • CASI N/A
  • WETH N/A
  • EPS Growth
  • CASI N/A
  • WETH 81.55
  • EPS
  • CASI N/A
  • WETH 0.62
  • Revenue
  • CASI $31,564,000.00
  • WETH $43,519,385.00
  • Revenue This Year
  • CASI N/A
  • WETH N/A
  • Revenue Next Year
  • CASI N/A
  • WETH N/A
  • P/E Ratio
  • CASI N/A
  • WETH $4.04
  • Revenue Growth
  • CASI 36.64
  • WETH 6.08
  • 52 Week Low
  • CASI $1.09
  • WETH $0.76
  • 52 Week High
  • CASI $5.95
  • WETH $3.68
  • Technical
  • Relative Strength Index (RSI)
  • CASI 35.39
  • WETH 57.06
  • Support Level
  • CASI $1.29
  • WETH $2.32
  • Resistance Level
  • CASI $1.48
  • WETH $2.97
  • Average True Range (ATR)
  • CASI 0.13
  • WETH 0.49
  • MACD
  • CASI -0.00
  • WETH -0.03
  • Stochastic Oscillator
  • CASI 0.00
  • WETH 41.67

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

Share on Social Networks: